David Kirn, Chief Executive Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 11,392 shares at $18.41 ($210K) on 2024-01-23, disclosed to the SEC on 2024-01-25.
Open-market sale of $210k FDMT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.41 | 5,696 | $105K | 50.0% |
| 2 | $18.41 | 5,696 | $105K | 50.0% |
| Total | $18.41 avg | 11,392 | $210K | 100% |
| Filing → |
| FDMT | SELL | 2026-08-21 | $1.1M | — | Filing → |
| FDMT | SELL | 2026-08-05 | $275K | — | Filing → |
| FDMT | SELL | 2026-08-04 | $125K | — | Filing → |